The Adelaide Cancer Seminar Series
The Adelaide Cancer Seminar Series are jointly organised by the Centre for Cancer Biology (CCB), South Australian immunoGENomics Cancer Institute (SAiGENCI) and the South Australian Health and Medical Research Institute (SAHMRI). The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.
Seminars take place on Thursdays between 12pm-1pm in University of South Australia (UniSA) Bradley Building, room HB8-18 and followed by a light lunch - All researchers are welcome to attend.
Seminar conveners are:
- A/Prof. Quenten Schwarz (CCB)
- Dr Guillermo Gomez (CCB)
- Dr Sarah Boyle (CCB)
- Dr Katherine Morel (SAiGENCI)
- Dr Zeyad Nassar (SAiGENCI)
- Dr Elyse Page (SAHMRI)
- Dr Stephen Blake (SAHMRI)
| Date | Day | Speaker | Institute | Host |
|---|---|---|---|---|
| 31-Aug-23 | Thursday | Luke Isbel | SAiGENCI | Greg Goodall |
| 7-Sep-23 | Thursday | Brendan Jenkins | SAiGENCI | Kat Morel/Mark Bunting |
| 14-Sep-23 | Thursday | Ajith Vasanthakumar | Olivia Newton John Cancer Research Institute | Michael Samuel |
| 21-Sep-23 | Thursday | Vashe Chandrakanthan | SAHMRI | Deb White |
| 28-Sep-23 | Thursday | Shahneen Sandhu | Peter MacCallum Cancer Centre | Lisa Ebert |
| 5-Oct-23 | Thursday | Ryash Vather | Royal Adelaide Hospital | Michael Samuel |
| 12-Oct-23 | Thursday | |||
| 19-Oct-23 | Thursday | |||
| 26-Oct-23 | Thursday | Stephen Birrell | Welland Health/HAVAH Therapeutics | Sarah Boyle |
News from CCB
Barossa Meeting
The Barossa Meetings have an established reputation for quality, with its aim of bringing together some of the world's best scientists across different disciplines in a convivial atmosphere conducive to open and energetic discussions.
The Clifford Prize for Cancer Research
The Clifford Prize for Cancer Research is an International Prize awarded in recognition of outstanding cancer research leading to significant clinical outcomes.
